Analysis Laboratories of the Poitiers CHU, Identification of the Mother or Fetus Contamination by SARS Cov-2, Research the Presence of Viruses at Different Sites of the Mother and the Fetus or Father, The Survey Builds on a Network Work Already Organized Around the CPDPN of Poitou-Charentes
Conditions
Brief summary
Maternal-fetal transmission in the second or third trimester of pregnancy of the SARS-COV-2 virus could explain some late fetal losses. Finding a cause in the context of fetal loss is essential for parents and caregivers. It helps to understand the history of the disease, to address the possible risk of a recurrence and to plan for future pregnancies. If the maternal-fetal transmission of COVID 19 is confirmed and that it is responsible for obstetric complications, a preventive action could be proposed to the patients by the preconception vaccination. The investigators are seeking to clarify the frequency of this transmission is information awaited by caregivers, women, couples in particular when the latter are in distress from late fetal loss.
Interventions
DIAGNOSTIC_TESTIdentification by PCR of the SARS-COV-2 virus in samples taken from the fetus
Identification by PCR of the SARS-COV-2 virus in samples taken from the fetus Presence of SARS-COV-2 virus in samples taken from mother and father. Circulating anti-SARS-COV-2 antibodies in the mother.
Sponsors
Poitiers University Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Healthy volunteers
Yes
Inclusion criteria
* Major patient * Patient with late spontaneous abortion (≥15 weeks of gestation) * Benefiting from a Social Security scheme * Patient who consented to participate in the study * Free subject, without tutorship, curatorship or subordination
Exclusion criteria
* Persons not benefiting from a Social Security scheme or not benefiting from it through a third party. * Concurrent participation in another clinical research study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Estimate the prevalence of SARS-CoV-2 infection in women with late fetal loss of unexplained cause. | 2 months | Identification by PCR of the SARS-COV-2 virus in samples taken from the fetus |
Countries
France
Outcome results
None listed